Biointerfaces Background 01

Category: Press Release

Evan Keller
Keller Named Director of Research Cores
February 18, 2022

Congratulations to Even Keller on joining OVPR as the inaugural Director of Research Cores.

Read Story
Kotov Lab & Univ. of Bath Researchers Discover New Photonic Effect
January 13, 2022

The collaboration developed a new photonic effect which could speed up the development of new antibiotics and drugs through automation.

Read Story
BI Welcomes Innovation Fellows
January 11, 2022

The Biointerfaces Institute is pleased to welcome our Inaugural Innovation Fellows, Dr. Anastasia Visheratina and Dr. Dylan Neale.

Read Story
Moon Lab Developes New Nanoparticle
October 1, 2021

The new nanoparticle discovery will revolutionize intravenous cancer immunotherapy.

Read Story
Lola Eniola-Adefeso named new Associate Dean for Graduate & Professional Education (ADGPE) in the College of Engineering
August 3, 2021

Lola Eniola-Adefeso named new Associate Dean for Graduate & Professional Education (ADGPE) in the College of Engineering

Read Story
BioInnovations in Brain Cancer launches faculty search
July 22, 2021

The BioInnovations in Brain Cancer Initiative (BIBC) at the University of Michigan invites applications for a tenure-track position at any level in brain cancer biology and technology research (including, drug/molecular transport/imaging in the brain tissue; translation-focused glioma, epigenetics and/or scRNA-seq research; and non-viral nucleic acid delivery).

Applications will be accepted on a rolling basis, but review of applications will begin on October 1, 2021.

Read Story
Tessier Lab Discovers New Protein Engineering Method
June 25, 2021

Researchers in the Tessier lab found a simple method for identifying nanobodies with drug-like properties suitable for preventing COVID-19 infections, which likely can be used to develop nanobodies against other viruses and disease targets.

Read Story
Faculty Promotions
May 21, 2021

Congratulations to James Moon, Sunitha Nagrath, Anna Schwendeman and Anish Tuteja on being promoted to Professor!

Read Story
BI Startup EVOQ Therapeutics inks agreement with Amgen
January 14, 2021

Under this license and collaboration agreement, EVOQ and Amgen will work on discovery and development of drugs for autoimmune disorders.

Read Story
Lola Eniola-Adefeso Joins MichBio Board
November 25, 2020

MichBio welcomed Lola Eniola-Adefeso to its Board of Directors where she will aid in the company’s efforts to drive future bio-industry growth.

Read Story

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us